跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 7, 2022
Approval ID
1498bd37611400ac
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
1498bd37611400ac
Drug Cima Aemps Name
ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES
Register Number
99125001IP3
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2022-11-07
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
OLANZAPINA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 7, 2022
Approval ID
1498bd37611400ac
Type
Standard
Back to CIMA-AEMPS Approvals
ZYPREXA VELOTAB 5 MG COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
